Name | AZD4721 |
---|
Description | AZD4721 (RIST4721) is the potent and orally active antagonist of acidic CXC chemokine receptor 2 (CXCR2). AZD4721 has the potential for the research of inflammatory disease[1]. |
---|---|
Related Catalog | |
Target |
CXCR2[1] |
In Vivo | Assessment of Pharmacokinetics (PK) profile of AZD4721 (RIST4721) in rat and dog[1] . In Vivo PK Rat Dog Predicted hepatic metabolic CL (ml/min per kilogram) 1.7 0.80 Observed CL (ml/min per kilogram) 2.4 0.50 CLrenal (mL/min per kilogram) <0.01 <0.01 CLbiliary (mL/min per kilogram) <0.01 0.04 In vivo/in vitro unbound CLintc 1.4 0.6 VSS (l/kg) 0.19 0.15 T1/2 (h) (PO) 1.3 3.7 (2.7) (8.4) F (%) 45 82 |
References |
Molecular Formula | C19H25FN4O5S2 |
---|---|
Molecular Weight | 472.55 |